Dr Reddy's Laboratories Ltd (RDY)
13.99
-0.31
(-2.17%)
USD |
NYSE |
Nov 21, 16:00
14.08
+0.09
(+0.64%)
Pre-Market: 07:34
Dr Reddy's Laboratories Revenue (Quarterly): 956.87M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 956.87M |
| March 31, 2024 | 852.90M |
| December 31, 2023 | 866.49M |
| September 30, 2023 | 832.09M |
| June 30, 2023 | 820.20M |
| March 31, 2023 | 766.58M |
| December 31, 2022 | 824.43M |
| September 30, 2022 | 790.40M |
| June 30, 2022 | 675.99M |
| March 31, 2022 | 722.88M |
| December 31, 2021 | 709.67M |
| September 30, 2021 | 777.79M |
| June 30, 2021 | 667.07M |
| March 31, 2021 | 648.45M |
| December 31, 2020 | 666.53M |
| September 30, 2020 | 656.94M |
| June 30, 2020 | 579.84M |
| March 31, 2020 | 610.26M |
| December 31, 2019 | 614.83M |
| September 30, 2019 | 680.72M |
| June 30, 2019 | 551.63M |
| March 31, 2019 | 569.54M |
| December 31, 2018 | 533.62M |
| September 30, 2018 | 541.33M |
| June 30, 2018 | 555.04M |
| Date | Value |
|---|---|
| March 31, 2018 | 549.32M |
| December 31, 2017 | 588.29M |
| September 30, 2017 | 551.59M |
| June 30, 2017 | 514.11M |
| March 31, 2017 | 530.64M |
| December 31, 2016 | 549.90M |
| September 30, 2016 | 535.67M |
| June 30, 2016 | 483.42M |
| March 31, 2016 | 556.39M |
| December 31, 2015 | 601.91M |
| September 30, 2015 | 614.45M |
| June 30, 2015 | 592.63M |
| March 31, 2015 | 621.76M |
| December 31, 2014 | 620.36M |
| September 30, 2014 | 591.85M |
| June 30, 2014 | 588.07M |
| March 31, 2014 | 563.30M |
| December 31, 2013 | 569.80M |
| September 30, 2013 | 540.64M |
| June 30, 2013 | 510.91M |
| March 31, 2013 | 616.30M |
| December 31, 2012 | 528.94M |
| September 30, 2012 | 521.96M |
| June 30, 2012 | 471.27M |
| March 31, 2012 | 393.06M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
579.84M
Minimum
Jun 2020
956.87M
Maximum
Sep 2024
738.96M
Average
722.88M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| 111 Inc | 476.09M |
| Zai Lab Ltd | 102.26M |
| Infosys Ltd | 4.894B |
| SS Innovations International Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 149.84M |
| Total Expenses (Quarterly) | 741.47M |
| EPS Diluted (Quarterly) | 0.0359 |
| Enterprise Value | 11.47B |
| Gross Profit Margin (Quarterly) | 59.59% |
| Profit Margin (Quarterly) | 15.66% |
| Earnings Yield | 3.34% |
| Operating Earnings Yield | 6.77% |
| Normalized Earnings Yield | 2.842 |